Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;60(6):769-775.
doi: 10.1007/s00120-021-01536-2. Epub 2021 May 20.

[Muscle-invasive bladder cancer]

[Article in German]
Jakob Büchler  1 , Jürgen E Gschwend  2 , Margitta Retz  2 , Sebastian C Schmid  2
Affiliations
Review

[Muscle-invasive bladder cancer]

[Article in German]
Jakob Büchler et al. Urologe A. 2021 Jun.

Abstract
in English, German

Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline "Early detection, diagnosis, treatment and aftercare of bladder cancer" are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options-ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy-are discussed on the basis of the current literature.

Das Blasenkarzinom stellt eine komplexe Erkrankung mit vielseitigen, stadienorientierten Therapieoptionen dar. Im Folgenden werden die Therapieempfehlungen der S3-Leitlinie „Früherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms“ auf ein fiktives Fallbeispiel übertragen. Bei einem Patienten mit invasivem Urothelkarzinom werden so die Therapieoptionen – von Blasenerhalt bis radikaler Zystektomie mit neoadjuvanter Chemotherapie – anhand der dazu vorliegenden Literatur diskutiert.

Keywords: BCG; Chemotherapy, neoadjuvant; Cystectomy; Transurethral resection; Urinary bladder neoplasms; Urinary division.

PubMed Disclaimer

References

Literatur

    1. Abe T, Takada N, Shinohara N et al (2014) Comparison of 90-day complications between ileal conduit and neobladder reconstruction after radical cystectomy: a retrospective multi-institutional study in Japan. Int J Urol 21:554–559 - DOI
    1. Ali AS, Hayes MC, Birch B et al (2015) Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol 41:295–299 - DOI
    1. Bohle A, Jocham D, Bock PR (2003) Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169:90–95 - DOI
    1. Burger M, Grossman HB, Droller M et al (2013) Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 64:846–854 - DOI
    1. Cerantola Y, Valerio M, Persson B et al (2013) Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS((R))) society recommendations. Clin Nutr 32:879–887 - DOI

LinkOut - more resources